The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $42.98

Today's change+0.14 +0.33%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $42.98

Today's change+0.14 +0.33%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories up (U.S.)$0.14

Abbott Laboratories closed up Friday by (U.S.)$0.14 or 0.33% to (U.S.)$42.98. Over the last five days, shares have lost 2.85% and are down 4.30% for the last year to date. This security has underperformed the S&P 500 by 14.05% during the last year.

Key company metrics

  • Open(U.S.) $42.72
  • Previous close(U.S.) $42.84
  • High(U.S.) $43.28
  • Low(U.S.) $42.09
  • Bid / Ask-- / --
  • YTD % change-4.30%
  • Volume18,670,546
  • Average volume (10-day)11,284,181
  • Average volume (1-month)10,310,642
  • Average volume (3-month)11,064,889
  • 52-week range(U.S.) $36.00 to (U.S.) $46.63
  • Beta1.13
  • Trailing P/E32.99×
  • P/E 1 year forward19.47×
  • Forward PEG2.08×
  • Indicated annual dividend(U.S.) $1.04
  • Dividend yield2.42%
  • Trailing EPS(U.S.) $1.30
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue5,3334,8855,1885,150
Total other revenue--------
Total revenue5,3334,8855,1885,150
Gross profit3,0522,7462,9662,941
Total cost of revenue2,2812,1392,2222,209
Total operating expense4,5174,3614,3734,437
Selling / general / administrative1,7461,6831,6561,640
Research & development348379375338
Depreciation / amortization145144143151
Interest expense (income), net operating--------
Unusual expense (income)-316-2399
Other operating expenses, total--------
Operating income816524815713
Interest income (expense), net non-operating-103-58-41-41
Gain (loss) on sale of assets--------
Other--------
Income before tax7152830714
Income after tax59956695596
Income tax, total116-54135118
Net income615316767580
Total adjustments to net income--------
Net income before extra. items59956695596
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items59956695596
Inc. avail. to common incl. extra. items615316767580
Diluted net income615316767580
Dilution adjustment00----
Diluted weighted average shares1,4801,4841,4971,505
Diluted EPS excluding extraordinary itemsvalue per share0.400.040.460.40
Dividends per sharevalue per share0.260.260.260.24
Diluted normalized EPSvalue per share0.400.040.450.45